The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Orchard Therapeutics (Netherlands) B.V.EU/1/20/1493/001

Main Information

Trade NameLibmeldy
Active SubstancesAutologous CD34+ cell enriched population that contains hematopoietic stem and progenitor cells transduced ex
Dosage FormDispersion for infusion
Licence HolderOrchard Therapeutics (Netherlands) B.V.
Licence NumberEU/1/20/1493/001

Group Information

ATC CodeA16AB21 atidarsagene autotemcel


License statusAuthorised
Licence Issued17/12/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back